Introduction

Feb 15, 2017 by in ONCOLOGY Comments Off on Introduction

© Springer International Publishing Switzerland 2016David Alberts, Maria Lluria-Prevatt, Stephanie Kha and Karen Weihs (eds.)Supportive Cancer Care10.1007/978-3-319-24814-1_1 1. Introduction David Alberts1  , Maria Lluria-Prevatt2  , Stephanie Kha2   and Karen Weihs2   (1) College of Medicine, University of Arizona, Tucson, AZ, USA (2) University of…

read more

Fundamentals of Cancer Pain Management

Feb 15, 2017 by in ONCOLOGY Comments Off on Fundamentals of Cancer Pain Management

Method Application Effectiveness Comments and references Opioids Somatic pain Neuropathic pain Mixed pain  In one underpowered randomized trial, methadone had no more effect than morphine in neuropathic pain Adjuvant drugs…

read more

Survivorship Care Planning

Feb 15, 2017 by in ONCOLOGY Comments Off on Survivorship Care Planning

© Springer International Publishing Switzerland 2016David Alberts, Maria Lluria-Prevatt, Stephanie Kha and Karen Weihs (eds.)Supportive Cancer Care10.1007/978-3-319-24814-1_6 6. Survivorship Care Planning Darcy Burbage1   (1) Department of Psychosocial Oncology and Survivorship, Helen F Graham Cancer Center and Research Institute,…

read more

Psychosocial Oncology

Feb 15, 2017 by in ONCOLOGY Comments Off on Psychosocial Oncology

© Springer International Publishing Switzerland 2016David Alberts, Maria Lluria-Prevatt, Stephanie Kha and Karen Weihs (eds.)Supportive Cancer Care10.1007/978-3-319-24814-1_3 3. Psychosocial Oncology Karen Weihs1, 2, 3, 4   (1) Department of Psychiatry, University of Arizona, Tucson, AZ, USA (2) Department of…

read more

Sirtuins as a Double-Edged Sword in Cancer: From Molecular Mechanisms to Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on Sirtuins as a Double-Edged Sword in Cancer: From Molecular Mechanisms to Therapeutic Opportunities

Conserved catalytic domain Activity Localization Principal targets under stress Regulation by CR/ROS Sirtuin function References Deacetylase Nucleus/cytoplasm H4K9Ac, H4K16Ac, SUV39h1, XPA, XPC, NBS1, hMOF, TIP60, WRN, Ku70, Rb, FOXO, HIF-1α,…

read more

Cell Cycle Checkpoint and DNA Damage Response Defects as Anticancer Targets: From Molecular Mechanisms to Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on Cell Cycle Checkpoint and DNA Damage Response Defects as Anticancer Targets: From Molecular Mechanisms to Therapeutic Opportunities

Fig. 3.1 The cell cycle and its checkpoints. Cyclins are individually synthesised and degraded in a phase distinctive manner and bind and activate specific Cdks which coordinates the sequential progression…

read more

p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities

Feb 15, 2017 by in ONCOLOGY Comments Off on p53 at the Crossroads Between Stress Response Signaling and Tumorigenesis: From Molecular Mechanisms to Therapeutic Opportunities

Fig. 4.1 The central part of the figure represents the p53 protein indicating its main domains: the N-terminal transactivation domain, the proline-rich domain, a central DNA binding core and a…

read more
Get Clinical Tree app for offline access